TwinBeech Capital’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
Other funds holding DYN
TwinBeech Capital's DYN Position: Q3 2026 in Review
TwinBeech Capital opened a new position in Dyne Therapeutics (DYN) in Q3 2026: 43,595 shares worth $702K. The stake represents 0.16% of the portfolio and ranks #175 among its holdings. This is a return to the name: TwinBeech Capital previously reported a position in DYN as recently as Q3 2025.
TwinBeech Capital first reported a position in DYN in Q1 2025 and has held it in 4 quarters since. The position peaked at $1.88M in Q2 2025. 266 funds tracked by Wall St. Rank hold DYN as of Q3 2026.
- TwinBeech Capital held 43,595 shares of Dyne Therapeutics worth $702K as of Q3 2026.
- Dyne Therapeutics was a new TwinBeech Capital position in Q3 2026.
- Dyne Therapeutics made up 0.16% of TwinBeech Capital's portfolio in Q3 2026, its #175 holding.
- TwinBeech Capital first reported a position in Dyne Therapeutics in Q1 2025 and has held it in 4 quarters since.
- TwinBeech Capital's Dyne Therapeutics position peaked at $1.88M in Q2 2025.
- 266 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q3 2026.
Based on TwinBeech Capital's 13F filing for Q3 2026, filed 16 Nov 2026.